The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
Hasan Yazıcı, Y Tüzün, Halit Pazarlı, Başak Yalçın, Sabahattin Yurdakul, Asuman Ü. Müftüoğlu
Abstract
Hasan Yazıcı, Y Tüzün, Halit Pazarlı, Başak Yalçın, Sabahattin Yurdakul, Asuman Ü. Müftüoğlu
Abstract
Forty-one of 49 (84%) patients with Behçet's disease in Turkey carried HLA-B5 (positive B5). Forty of the same 49 (82%) patients had a nonspecific skin hyperreactivity to needle prick (positive pathergy). There were no patients in whom both of these tests were negative.
OpenAlex reports 47 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Forty-one of 49 (84%) patients with Behçet's disease in Turkey carried HLA-B5 (positive B5). Forty of the same 49 (82%) patients had a nonspecific skin hyperreactivity to needle prick (positive pathergy). There were no patients in whom both of these tests were negative.
Key concepts: Pathergy, Medicine, Behcet's disease, Dermatology, Disease, Surgery, Internal medicine